In the current proposal, the investigators aim to investigate the virological and clinical
effects of chloroquine treatment in patients with established COVID-19 in need of hospital
admission. Patients will be randomized in a 1:1 fashion to standard of care or standard of
care with the addition of therapy with chloroquine.